Impact of the Novel Coronavirus 2019 (COVID-19) Pandemic on Head and Neck Cancer Care
AuthorThompson, Joshua Adam
Lubek, Joshua E
Ord, Robert A
Taylor, Rodney J
Wolf, Jeffrey S
Cullen, Kevin J
Molitoris, Jason K
Papadimitriou, John C
Morales, Robert E
Hatten, Kyle M
JournalOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
PublisherSAGE Publications Inc.
MetadataShow full item record
AbstractObjective: The study aimed to assess the impact of the coronavirus disease 2019 (COVID-19) pandemic on head and neck oncologic care at a tertiary care facility. Study Design: This was a cross-sectional study conducted between March 18, 2020, and May 20, 2020. The primary planned outcome was the rate of treatment modifications during the study period. Secondary outcome measures were tumor conference volume, operative volume, and outpatient patient procedure and clinic volumes. Setting: This single-center study was conducted at a tertiary care academic hospital in a large metropolitan area. Methods: The study included a consecutive sample of adult subjects who were presented at a head and neck interdepartmental tumor conference during the study period. Patients were compared to historical controls based on review of operative data, outpatient procedures, and clinic volumes. Results: In total, 117 patients were presented during the review period in 2020, compared to 69 in 2019. There was an 8.4% treatment modification rate among cases presented at the tumor conference. There was a 61.3% (347 from 898) reduction in outpatient clinic visits and a 63.4% (84 from 230) reduction in procedural volume compared to the prior year. Similarly, the operative volume decreased by 27.0% (224 from 307) compared to the previous year. Conclusion: Restrictions related to the COVID-19 pandemic resulted in limited treatment modifications. Transition to virtual tumor board format observed an increase in case presentations. While there were reductions in operative volume, there was a larger proportion of surgical cases for malignancy, reflecting the prioritization of oncologic care during the pandemic.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/15129
- Managing head and neck cancer patients during the COVID-19 pandemic: the experience of a tertiary referral center in southern Italy.
- Authors: Longo F, Trecca EMC, D'Ecclesia A, Copelli C, Tewfik K, Manfuso A, Pederneschi N, Mastromatteo A, Russo MA, Pansini A, Lacerenza LM, Marano PG, Cassano L
- Issue date: 2021 Feb 5
- Uniform infection screening allowed safe head and neck surgery during the coronavirus disease 2019 pandemic in Japan.
- Authors: Ito A, Kobayashi K, Shiotsuka M, Sato T, Omura G, Matsumoto Y, Ikeda A, Sakai A, Eguchi K, Takano T, Matsumoto F, Kobayashi O, Iwata S, Yoshimoto S
- Issue date: 2021 Mar 3
- Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era.
- Authors: Kiong KL, Guo T, Yao CMKL, Gross ND, Hanasono MM, Ferrarotto R, Rosenthal DI, Myers JN, Hanna EY, Lai SY
- Issue date: 2020 Jun
- Head and neck oncologic surgery in the COVID-19 pandemic: Our experience in a deep south tertiary care center.
- Authors: Morrison DR, Gentile C, McCammon S, Buczek E
- Issue date: 2020 Jul
- Effect of coronavirus disease 2019 pandemic on case volume, spectrum, and perioperative coronavirus disease 2019 incidence in neurosurgical patients: An experience at a tertiary care center in India.
- Authors: Sharma AK, Gandhoke CS, Nayak N
- Issue date: 2020